Log in
Enquire now
‌

Salvia BioElectronics

Manufacturer of neuromodulation devices for migraine treatment and management.

OverviewStructured DataIssuesContributors

Contents

salviabioelectronics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Manufacturing
Manufacturing
‌
Neuromodulation
Health technology
Health technology
Medical device
Medical device
Biotechnology
Biotechnology
B2X
B2B
B2B
CEO
‌
Hubert Martens
Founder
Wim Pollet
Wim Pollet
‌
Hubert Martens
‌
Daniel Schobben
Number of Employees (Ranges)
11 – 50
Email Address
mb.info@salvianeuro.com
Full Address
High Tech Campus 41 5656 AE Eindhoven The Netherlands
Investors
EIC Accelerator
EIC Accelerator
Thuja Capital
Thuja Capital
Inkef Capital
Inkef Capital
Panakes Partners
Panakes Partners
Dolby Family Ventures
Dolby Family Ventures
Innovation Industries
Innovation Industries
‌
Invest-NL
‌
SHS Capital
...
Founded Date
March 3, 2017
Total Funding Amount (USD)
90,400,000
Latest Funding Round Date
May 27, 2025
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
COO
‌
Daniel Schobben
Country
Netherlands
Netherlands
Headquarters
Eindhoven
Eindhoven

Other attributes

Latest Funding Round Amount (USD)
60,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Salvia BioElectronics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.